prof. MUDr. Jiří Mayer, CSc.
Department head, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3643, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 1619
2021
-
Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype
Acta Oncologica, year: 2021, volume: 60, edition: 6, DOI
-
Half: A prospective Multi-Centre phase II clinical trial evaluating the efficacy and safety of tyrosine kinase inhibitors' discontinuation after two-step dose reduction in patients with chronic myeloid leukemia in deep molecular remission.
Year: 2021, type: Conference abstract
-
HALF: Multicentrická akademická studie fáze II vysazující inhibitory tyrozinkináz po dvoustupňové redukci dávky u pacientů s chronickou myeloidní leukémií – první výsledky.
Year: 2021, type: Conference abstract
-
HALF: Národní klinická studie fáze 2 s postupným vysazováním inhibitorů tyrosinové kinázy (TKI) u pacientů s chronickou myeloidní leukemií (CML) – průběžné výsledky.
Year: 2021, type: Conference abstract
-
Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow-up
British journal of haematology, year: 2021, volume: 194, edition: 3, DOI
-
How to select older patients with acute myeloid leukemia fit for intensive treatment?
Hematological Oncology, year: 2021, volume: 39, edition: 2, DOI
-
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study
British journal of haematology, year: 2021, volume: 192, edition: 5, DOI
-
Ibrutinib Blocks CD40 Signalling in CLL in Vivo by Reducing TRAF4 Levels.
Year: 2021, type: Conference abstract
-
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3K delta inhibitor idelalisib
haematologica, year: 2021, volume: 106, edition: 11, DOI
-
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
BLOOD ADVANCES, year: 2021, volume: 5, edition: 17, DOI